In March 2025, Leavitt Partners, an HMA Company, in conjunction with a number of multi-sector stakeholders, released Kill the Clipboard! A Federal Policy and Industry Roadmap to Accelerate Innovation and Cut Administrative Waste. Just three months later, the U.S. Department of Health and Human Services released its Request for Information (RFI) on the Health Technology Ecosystem. The priorities in the RFI closely reflect the multi-sector roadmap’s recommendations, underscoring the influence and relevance of effective public/private sector collaboration. This session will explore how the paper and the RFI’s recommendations on interoperability, TEFCA modernization, digital identity, patient access, and administrative burden reduction can reduce unnecessary burden and waste. The presenters will also discuss how this alignment offers a path forward for policy leaders, healthcare organizations, and technology partners committed to modernizing the U.S. health system.
Speakers:
- Ryan Howells, Principal, Leavitt Partners, an HMA Company
- Aneesh Chopra, Chief Strategy Officer, Arcadia
Learning Objectives:
- Identify key policy alignments on how the RFI on the Health Technology Ecosystem relates to other ongoing open industry initiatives.
- Understand the implications of an API-first architecture, open standards, and federal coordination for advancing interoperability and reducing administrative waste.
- Recognize actionable strategies that stakeholders can adopt to align with emerging national digital health priorities.
Medicare Advantage plans in the United States continue to explode in popularity, now reaching over 30 million Americans, due to the broad appeal of supplemental benefits that can be offered by plans to enrollees. What started off as a core set of benefit offerings, including dental, vision, and over-the-counter medications, has recently been expanded by Congress and Administrations to include a wider range of both health and non-health benefits. While this expansion has brought significant innovation in care delivery models, it has also brought questions around validating benefit value. In this white paper, Matt Gallivan, director at Leavitt Partners, an HMA company, outlines the expansion of supplemental benefit offerings, highlights both the innovations and opportunities for improvement in the existing benefit models, and makes recommendations around increasing transparency, protecting patients, and validating benefit value.